Fulton Breakefield Broenniman LLC lowered its holdings in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 3.1% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 57,626 shares of the healthcare conglomerate's stock after selling 1,821 shares during the period. UnitedHealth Group comprises 2.2% of Fulton Breakefield Broenniman LLC's holdings, making the stock its 15th biggest holding. Fulton Breakefield Broenniman LLC's holdings in UnitedHealth Group were worth $30,182,000 as of its most recent SEC filing.
Other large investors have also recently added to or reduced their stakes in the company. Marshall & Sterling Wealth Advisors Inc. purchased a new position in UnitedHealth Group in the 4th quarter worth about $26,000. Hurley Capital LLC purchased a new stake in UnitedHealth Group in the 4th quarter worth about $28,000. Aster Capital Management DIFC Ltd acquired a new position in shares of UnitedHealth Group in the 4th quarter valued at about $30,000. Kapitalo Investimentos Ltda acquired a new stake in shares of UnitedHealth Group during the fourth quarter worth approximately $41,000. Finally, Copia Wealth Management purchased a new stake in UnitedHealth Group in the 4th quarter worth approximately $42,000. 87.86% of the stock is currently owned by institutional investors.
Analyst Ratings Changes
A number of equities research analysts have recently weighed in on UNH shares. TD Securities reaffirmed a "hold" rating and set a $308.00 price target (down from $520.00) on shares of UnitedHealth Group in a research note on Monday, May 19th. Wall Street Zen cut shares of UnitedHealth Group from a "buy" rating to a "hold" rating in a research note on Saturday, May 24th. Bank of America cut shares of UnitedHealth Group from a "buy" rating to a "neutral" rating and decreased their price objective for the stock from $560.00 to $350.00 in a report on Wednesday, May 14th. Truist Financial restated a "buy" rating and issued a $360.00 target price (down from $580.00) on shares of UnitedHealth Group in a report on Monday, May 19th. Finally, Mizuho dropped their price target on shares of UnitedHealth Group from $515.00 to $350.00 and set an "outperform" rating on the stock in a research report on Friday, May 16th. One equities research analyst has rated the stock with a sell rating, nine have given a hold rating and sixteen have given a buy rating to the company. According to data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus price target of $415.00.
View Our Latest Analysis on UnitedHealth Group
UnitedHealth Group Price Performance
NYSE UNH traded down $4.40 during trading hours on Monday, reaching $299.70. 3,465,601 shares of the company's stock were exchanged, compared to its average volume of 7,688,536. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.71. The stock has a market cap of $271.87 billion, a PE ratio of 12.55, a price-to-earnings-growth ratio of 1.46 and a beta of 0.45. The firm has a fifty day moving average of $314.52 and a 200-day moving average of $439.94. UnitedHealth Group Incorporated has a one year low of $248.88 and a one year high of $630.73.
UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). The company had revenue of $109.58 billion during the quarter, compared to analyst estimates of $111.56 billion. UnitedHealth Group had a net margin of 5.39% and a return on equity of 26.29%. During the same period in the prior year, the business earned $6.91 EPS. On average, equities research analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.
UnitedHealth Group Increases Dividend
The company also recently declared a quarterly dividend, which was paid on Tuesday, June 24th. Stockholders of record on Monday, June 16th were given a dividend of $2.21 per share. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.95%. This is a boost from UnitedHealth Group's previous quarterly dividend of $2.10. The ex-dividend date was Monday, June 16th. UnitedHealth Group's dividend payout ratio (DPR) is currently 37.02%.
Insider Buying and Selling at UnitedHealth Group
In related news, CEO Patrick Hugh Conway sold 589 shares of UnitedHealth Group stock in a transaction that occurred on Tuesday, June 10th. The stock was sold at an average price of $305.00, for a total value of $179,645.00. Following the sale, the chief executive officer owned 10,398 shares of the company's stock, valued at approximately $3,171,390. This trade represents a 5.36% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Kristen Gil bought 3,700 shares of the stock in a transaction that occurred on Thursday, May 15th. The stock was bought at an average cost of $271.17 per share, for a total transaction of $1,003,329.00. Following the transaction, the director owned 3,818 shares of the company's stock, valued at $1,035,327.06. The trade was a 3,135.59% increase in their position. The disclosure for this purchase can be found here. Insiders have acquired a total of 109,408 shares of company stock worth $31,607,768 in the last three months. 0.28% of the stock is owned by insiders.
UnitedHealth Group Company Profile
(
Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
See Also

Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for July 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report